文献速递冠心病心力衰竭与心肌病心律失常

参与责任医疗组织与心血管照护质量的关系

Accountable Care Organization Participation and Cardiovascular Care Quality.
PubMed 文献 · JAMA Cardiol · 2025-01-01

本研究比较83家参与 Medicare 共享节约计划(MSSP)责任医疗组织(ACO)的门诊心血管执业机构与332家未参与机构,在2013至2019年间15项质量指标的变化。主要分析未发现参与ACO与冠心病、心衰、房颤和高血压质量指标的差异性改变相关;探索性分析延长随访至24个月时,心衰β受体阻滞剂使用增加、LDL低于100 mg/dL的比例下降。

要点

  • 参与MSSP ACO未带来门诊心血管质量指标的早期改善
  • 探索性24个月随访见心衰β受体阻滞剂使用增加、LDL达标率下降
  • 传统Medicare亚组中ACO参与后12个月ICD使用增加

核心结论

  • 参与MSSP ACO与门诊心血管执业机构质量指标的早期改善无关。

研究设计与样本

  • 前后对照队列研究,比较83家ACO门诊心血管执业机构与332家非ACO参与机构,使用2013年1月1日至2019年3月31日PINNACLE注册数据,调整长期趋势,分析15项质量指标。

主要发现

  • ACO执业机构照护2 390 244例患者(53.3%女性,平均年龄58.5岁),非ACO机构照护5 415 880例患者(51.9%女性,平均年龄61.5岁)。
  • 主要分析中,冠心病、心衰、房颤和高血压的多项质量指标未见差异性改变。

临床怎么用

  • 参与ACO未必能在短期内提升门诊心血管质量指标,需关注长期随访中的变化信号。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The Medicare Shared Savings Program (MSSP) was introduced in 2012 to improve care quality and lower costs to Medicare. Under this program, accountable care organizations (ACOs) assumed responsibility for costs and care quality for a group of Medicare beneficiaries. OBJECTIVE: To compare changes in quality measures for patients at outpatient cardiology practices before and after their participation in a Medicare Shared Savings Program ACO. DESIGN, SETTING, AND PARTICIPANTS: This pre-post cohort study comparing quality prior to and after ACO participation evaluated the MSSP at 83 ACO outpatient cardiology practices compared with 332 non-ACO-participating cardiology practices, adjusted for secular trends, using 15 performance measures in the National Cardiovascular Data Registry PINNACLE (Practice Innovation and Clinical Excellence) Registry from January 1, 2013, through March 31, 2019. Data analysis was performed from 2022 to 2025. EXPOSURES: Outpatient cardiology practice participation in the MSSP, which allows ACOs to share in the savings if predetermined cost targets are met, with payments adjusted based on a quality performance score. MAIN OUTCOMES AND MEASURES: Primary end points included 15 quality measures for coronary artery disease, heart failure, atrial fibrillation, and hypertension. RESULTS: During the study period, 2 390 244 patients (1 273 615 [53.3%] female; mean [SD] age, 58.5 [17.7] years) were cared for by 83 ACO practices, and 5 415 880 patients (2 810 204 [51.9%] female; mean [SD] age, 61.5 [16.3] years) were cared for by 332 non-ACO practices. Outpatient cardiology practice participation in an MSSP ACO was not associated with differential changes in various performance measures for coronary artery disease, heart failure, atrial fibrillation, and hypertension. There were no differential changes in the odds of β-blocker prescription, blood pressure control, antiplatelet prescription, angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) prescription, low-density lipoprotein (LDL) profiles, or smoking cessation for coronary artery disease; left ventricular assessment, β-blocker prescription, ACEI or ARB prescription, or implantable cardioverter defibrillator use for heart failure; anticoagulation for atrial fibrillation; or blood pressure control for hypertension. Exploratory analyses extending follow-up to 24 months revealed an increase in β-blocker use for heart failure (adjusted odds ratio [aOR], 1.23; 95% CI, 1.02-1.49; P = .03) and a decline in LDL profiles less than 100 mg/dL (to convert to millimoles per liter, multiply by 0.0259; aOR, 0.71; 95% CI, 0.51-0.999; P = .049). Among a subset of traditional Medicare patients, there was an increase in implantable cardioverter defibrillator use by 12 months (aOR, 1.66; 95% CI, 1.12-2.45; P = .01) following ACO participation. CONCLUSIONS AND RELEVANCE: Participation in an MSSP ACO was not found to be associated with early improvement in quality measures at outpatient cardiology practices.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Spatz ES, Oddleifson DA, Kayani J, et al. Accountable Care Organization Participation and Cardiovascular Care Quality. JAMA Cardiol. 2025. PMID: 40172907. doi:10.1001/jamacardio.2025.0381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。